Abstract

BackgroundCoronary inflammation induces dynamic changes in the balance between water and lipid content in perivascular adipose tissue (PVAT), as captured by perivascular Fat Attenuation Index (FAI) in standard coronary CT angiography (CCTA). However, inflammation is not the only process involved in atherogenesis and we hypothesized that additional radiomic signatures of adverse fibrotic and microvascular PVAT remodelling, may further improve cardiac risk prediction.Methods and resultsWe present a new artificial intelligence-powered method to predict cardiac risk by analysing the radiomic profile of coronary PVAT, developed and validated in patient cohorts acquired in three different studies. In Study 1, adipose tissue biopsies were obtained from 167 patients undergoing cardiac surgery, and the expression of genes representing inflammation, fibrosis and vascularity was linked with the radiomic features extracted from tissue CT images. Adipose tissue wavelet-transformed mean attenuation (captured by FAI) was the most sensitive radiomic feature in describing tissue inflammation (TNFA expression), while features of radiomic texture were related to adipose tissue fibrosis (COL1A1 expression) and vascularity (CD31 expression). In Study 2, we analysed 1391 coronary PVAT radiomic features in 101 patients who experienced major adverse cardiac events (MACE) within 5 years of having a CCTA and 101 matched controls, training and validating a machine learning (random forest) algorithm (fat radiomic profile, FRP) to discriminate cases from controls (C-statistic 0.77 [95%CI: 0.62–0.93] in the external validation set). The coronary FRP signature was then tested in 1575 consecutive eligible participants in the SCOT-HEART trial, where it significantly improved MACE prediction beyond traditional risk stratification that included risk factors, coronary calcium score, coronary stenosis, and high-risk plaque features on CCTA (Δ[C-statistic] = 0.126, P < 0.001). In Study 3, FRP was significantly higher in 44 patients presenting with acute myocardial infarction compared with 44 matched controls, but unlike FAI, remained unchanged 6 months after the index event, confirming that FRP detects persistent PVAT changes not captured by FAI.ConclusionThe CCTA-based radiomic profiling of coronary artery PVAT detects perivascular structural remodelling associated with coronary artery disease, beyond inflammation. A new artificial intelligence (AI)-powered imaging biomarker (FRP) leads to a striking improvement of cardiac risk prediction over and above the current state-of-the-art.

Highlights

  • Coronary artery disease (CAD) remains a leading cause of morbidity and mortality despite advances in primary and secondary prevention strategies.[1]

  • Radiotranscriptomic analysis of human adipose tissue revealed that wavelet-transformed mean attenuation was the best-performing metric for detection of adipose tissue inflammation, as assessed by the relative expression of TNFA (Figure 2A)

  • Radiomic phenotyping of coronary Perivascular adipose tissue (PVAT) around the right coronary artery (RCA) and left anterior descending artery (LCA) produced a total of 1686 radiomic features (843 features around each vessel; Supplementary material online, Figure S1 and Figure 2A)

Read more

Summary

Introduction

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality despite advances in primary and secondary prevention strategies.[1] Coronary CT angiography (CCTA) is a first line investigation for the assessment of possible CAD.[2,3,4] The CCTA traditionally relies on the detection of obstructive lesions or coronary calcification to guide cardiovascular risk stratification and clinical decision-making.[5,6] optimal medical therapy and clinical risk factor management do not always prevent acute coronary syndromes, resulting in the concept of ‘residual cardiovascular risk’, a major factor driving uncertainty in risk stratification and targeting of healthcare interventions.[7,8] Vascular inflammation, in particular, is recognized as a major contributor to both atherosclerotic plaque formation and destabilization.[7,8] conventional tests such as circulating inflammatory biomarkers are not specific enough to identify coronary inflammation, and advanced imaging tests (e.g. positron emission tomography-CT using 18F-NaF)[9,10] are costly and not widely available, limiting their current use in clinical practice.[11,12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call